ArriVent BioPharma, Inc.ArriVent BioPharma, Inc.ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−1.08USD
Revenue estimate
Market capitalization
‪553.32 M‬USD
‪−69.33 M‬USD
‪21.17 M‬
Beta (1Y)
0.56

About ArriVent BioPharma, Inc.

CEO
Zheng Bin Yao
Headquarters
Newtown Square
Employees (FY)
40
Founded
2021
FIGI
BBG011N37VQ0
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AVBP is 16.69 USD — it has increased by 1.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ArriVent BioPharma, Inc. stocks are traded under the ticker AVBP.
ArriVent BioPharma, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
AVBP stock is 10.36% volatile and has beta coefficient of 0.56. Check out the list of the most volatile stocks — is ArriVent BioPharma, Inc. there?
Yes, you can track ArriVent BioPharma, Inc. financials in yearly and quarterly reports right on TradingView.
AVBP stock has risen by 6.71% compared to the previous week, the month change is a 6.86% fall, over the last year ArriVent BioPharma, Inc. has showed a 30.46% decrease.
AVBP net income for the last quarter is ‪−21.19 M‬ USD, while the quarter before that showed ‪−14.40 M‬ USD of net income which accounts for −47.16% change. Track more ArriVent BioPharma, Inc. financial stats to get the full picture.
No, AVBP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AVBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ArriVent BioPharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AVBP reached its all-time high on Jan 26, 2024 with the price of 25.95 USD, and its all-time low was 14.35 USD and was reached on Apr 25, 2024.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 40.00 employees. See our rating of the largest employees — is ArriVent BioPharma, Inc. on this list?
We've gathered analysts' opinions on ArriVent BioPharma, Inc. future price: according to them, AVBP price has a max estimate of 35.00 USD and a min estimate of 25.00 USD. Read a more detailed ArriVent BioPharma, Inc. forecast: see what analysts think of ArriVent BioPharma, Inc. and suggest that you do with its stocks.